drugset / Trial / NCT02170649

The Tolerability and Effect of Food on the Pharmacokinetics of a Single 800 mg Oral Dose of BIA 2-093

NCT02170649

Phase 1 Completed 12 enrolled Bial - Portela C S.A.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the effect of food on the pharmacokinetics of a single 800 mg oral dose of BIA 2-093 in healthy volunteers.

Timeline

Start
2001-09
Primary completion
2001-11
Completion
2001-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Eslicarbazepine acetate Unknown 800 mg Oral

Indications